Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)
Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl
Gespeichert in:
| Veröffentlicht in: | Peritoneal dialysis international 2001-09, Vol.21 (5), p.480-486 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 486 |
|---|---|
| container_issue | 5 |
| container_start_page | 480 |
| container_title | Peritoneal dialysis international |
| container_volume | 21 |
| creator | de Fijter, CW ter Wee, PM Oe, LP Verbrugh, HA |
| description | Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl |
| doi_str_mv | 10.1177/089686080102100509 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72330965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72330965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-138e5bd8ad60d6728bed6f11389bbd1ecdb4a758bdd4c5590c59c7867463116d3</originalsourceid><addsrcrecordid>eNplkc1u1DAUhS0EokPhBVggb0B0EbiOk9jprhoKjFSJEYK15dg3jJHzg-10gLfiDfGokYrEyrrWd86x7yHkOYM3jAnxFmTbyAYkMCgZQA3tA7Jhgsmi4lA9JJsTUJyIM_Ikxu8AvOQgHpOzLK-F5OWG_NmNKegZg0vTiNpT4-Yw9X76qY0bqR4tDa7Xw-xO4y2GuERqcD4Ebd2IVEfqRpdcVqaAOg04Jjr19PX24mr_rgjodUJL14AMxkuqaY6IM5rkbpGGnDEN7nemhsUnZ7IDBmqmYdbBxWnMXrv9_vpzDsgxF0_Jo177iM_W85x8fX_9ZfuxuPn0Ybe9uilMBTwVjEusOyu1bcA2opQd2qZn-brtOsvQ2K7SopadtZWp6xZM3RohG1E1nLHG8nPy6s43P_bHgjGpwUWD3usRpyUqUXIObVNnsLwDTf5VDNirObhBh1-KgToVpf4vKoterO5LN6C9l6zNZODlCuhotO_zmoyL91wFkkP5D3dw3w5HF1DFQXufbUt1PB5LpmpVSeB_Achtq70</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72330965</pqid></control><display><type>article</type><title>Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)</title><source>MEDLINE</source><source>SAGE Complete</source><creator>de Fijter, CW ; ter Wee, PM ; Oe, LP ; Verbrugh, HA</creator><creatorcontrib>de Fijter, CW ; ter Wee, PM ; Oe, LP ; Verbrugh, HA ; for the CIPPER Trial Group</creatorcontrib><description>Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl</description><identifier>ISSN: 0896-8608</identifier><identifier>EISSN: 1718-4304</identifier><identifier>DOI: 10.1177/089686080102100509</identifier><identifier>PMID: 11757832</identifier><language>eng</language><publisher>Milton, ON: Multimed</publisher><subject><![CDATA[Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anti-Infective Agents - administration & dosage ; Anti-Infective Agents - therapeutic use ; Antibacterial agents ; Antibiotics, Antitubercular - administration & dosage ; Antibiotics, Antitubercular - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cephalosporins - administration & dosage ; Cephalosporins - therapeutic use ; Cephradine - administration & dosage ; Cephradine - therapeutic use ; Ciprofloxacin - administration & dosage ; Ciprofloxacin - therapeutic use ; Drug Therapy, Combination ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Humans ; Infusions, Parenteral ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Peritoneal Dialysis, Continuous Ambulatory - adverse effects ; Peritonitis - drug therapy ; Peritonitis - etiology ; Peritonitis - microbiology ; Pharmacology. Drug treatments ; Prospective Studies ; Rifampin - administration & dosage ; Rifampin - therapeutic use ; Staphylococcus aureus - isolation & purification ; Treatment Outcome]]></subject><ispartof>Peritoneal dialysis international, 2001-09, Vol.21 (5), p.480-486</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-138e5bd8ad60d6728bed6f11389bbd1ecdb4a758bdd4c5590c59c7867463116d3</citedby><cites>FETCH-LOGICAL-c403t-138e5bd8ad60d6728bed6f11389bbd1ecdb4a758bdd4c5590c59c7867463116d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14083022$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11757832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Fijter, CW</creatorcontrib><creatorcontrib>ter Wee, PM</creatorcontrib><creatorcontrib>Oe, LP</creatorcontrib><creatorcontrib>Verbrugh, HA</creatorcontrib><creatorcontrib>for the CIPPER Trial Group</creatorcontrib><title>Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)</title><title>Peritoneal dialysis international</title><addtitle>Perit Dial Int</addtitle><description>Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anti-Infective Agents - administration & dosage</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics, Antitubercular - administration & dosage</subject><subject>Antibiotics, Antitubercular - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cephalosporins - administration & dosage</subject><subject>Cephalosporins - therapeutic use</subject><subject>Cephradine - administration & dosage</subject><subject>Cephradine - therapeutic use</subject><subject>Ciprofloxacin - administration & dosage</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</subject><subject>Peritonitis - drug therapy</subject><subject>Peritonitis - etiology</subject><subject>Peritonitis - microbiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Rifampin - administration & dosage</subject><subject>Rifampin - therapeutic use</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Treatment Outcome</subject><issn>0896-8608</issn><issn>1718-4304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkc1u1DAUhS0EokPhBVggb0B0EbiOk9jprhoKjFSJEYK15dg3jJHzg-10gLfiDfGokYrEyrrWd86x7yHkOYM3jAnxFmTbyAYkMCgZQA3tA7Jhgsmi4lA9JJsTUJyIM_Ikxu8AvOQgHpOzLK-F5OWG_NmNKegZg0vTiNpT4-Yw9X76qY0bqR4tDa7Xw-xO4y2GuERqcD4Ebd2IVEfqRpdcVqaAOg04Jjr19PX24mr_rgjodUJL14AMxkuqaY6IM5rkbpGGnDEN7nemhsUnZ7IDBmqmYdbBxWnMXrv9_vpzDsgxF0_Jo177iM_W85x8fX_9ZfuxuPn0Ybe9uilMBTwVjEusOyu1bcA2opQd2qZn-brtOsvQ2K7SopadtZWp6xZM3RohG1E1nLHG8nPy6s43P_bHgjGpwUWD3usRpyUqUXIObVNnsLwDTf5VDNirObhBh1-KgToVpf4vKoterO5LN6C9l6zNZODlCuhotO_zmoyL91wFkkP5D3dw3w5HF1DFQXufbUt1PB5LpmpVSeB_Achtq70</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>de Fijter, CW</creator><creator>ter Wee, PM</creator><creator>Oe, LP</creator><creator>Verbrugh, HA</creator><general>Multimed</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)</title><author>de Fijter, CW ; ter Wee, PM ; Oe, LP ; Verbrugh, HA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-138e5bd8ad60d6728bed6f11389bbd1ecdb4a758bdd4c5590c59c7867463116d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anti-Infective Agents - administration & dosage</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics, Antitubercular - administration & dosage</topic><topic>Antibiotics, Antitubercular - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cephalosporins - administration & dosage</topic><topic>Cephalosporins - therapeutic use</topic><topic>Cephradine - administration & dosage</topic><topic>Cephradine - therapeutic use</topic><topic>Ciprofloxacin - administration & dosage</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</topic><topic>Peritonitis - drug therapy</topic><topic>Peritonitis - etiology</topic><topic>Peritonitis - microbiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Rifampin - administration & dosage</topic><topic>Rifampin - therapeutic use</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Fijter, CW</creatorcontrib><creatorcontrib>ter Wee, PM</creatorcontrib><creatorcontrib>Oe, LP</creatorcontrib><creatorcontrib>Verbrugh, HA</creatorcontrib><creatorcontrib>for the CIPPER Trial Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Peritoneal dialysis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Fijter, CW</au><au>ter Wee, PM</au><au>Oe, LP</au><au>Verbrugh, HA</au><aucorp>for the CIPPER Trial Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)</atitle><jtitle>Peritoneal dialysis international</jtitle><addtitle>Perit Dial Int</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>21</volume><issue>5</issue><spage>480</spage><epage>486</epage><pages>480-486</pages><issn>0896-8608</issn><eissn>1718-4304</eissn><abstract>Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl</abstract><cop>Milton, ON</cop><pub>Multimed</pub><pmid>11757832</pmid><doi>10.1177/089686080102100509</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0896-8608 |
| ispartof | Peritoneal dialysis international, 2001-09, Vol.21 (5), p.480-486 |
| issn | 0896-8608 1718-4304 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72330965 |
| source | MEDLINE; SAGE Complete |
| subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Infective Agents - administration & dosage Anti-Infective Agents - therapeutic use Antibacterial agents Antibiotics, Antitubercular - administration & dosage Antibiotics, Antitubercular - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cephalosporins - administration & dosage Cephalosporins - therapeutic use Cephradine - administration & dosage Cephradine - therapeutic use Ciprofloxacin - administration & dosage Ciprofloxacin - therapeutic use Drug Therapy, Combination Emergency and intensive care: renal failure. Dialysis management Female Humans Infusions, Parenteral Intensive care medicine Male Medical sciences Middle Aged Peritoneal Dialysis, Continuous Ambulatory - adverse effects Peritonitis - drug therapy Peritonitis - etiology Peritonitis - microbiology Pharmacology. Drug treatments Prospective Studies Rifampin - administration & dosage Rifampin - therapeutic use Staphylococcus aureus - isolation & purification Treatment Outcome |
| title | Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A43%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intraperitoneal%20ciprofloxacin%20and%20rifampicin%20versus%20cephradine%20as%20initial%20treatment%20of%20(C)APD-related%20peritonitis:%20a%20prospective%20randomized%20multicenter%20comparison%20(CIPPER%20trial)&rft.jtitle=Peritoneal%20dialysis%20international&rft.au=de%20Fijter,%20CW&rft.aucorp=for%20the%20CIPPER%20Trial%20Group&rft.date=2001-09-01&rft.volume=21&rft.issue=5&rft.spage=480&rft.epage=486&rft.pages=480-486&rft.issn=0896-8608&rft.eissn=1718-4304&rft_id=info:doi/10.1177/089686080102100509&rft_dat=%3Cproquest_cross%3E72330965%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72330965&rft_id=info:pmid/11757832&rfr_iscdi=true |